| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.25 | 0.005 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |